Pain, cancer, fibromyalgia and gastrointestinal disorders

Raffaele Manni, Riccardo Cremascoli, Michele Terzaghi

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

Daytime sleepiness is very frequent in chronic pain sufferers and it is underpinned by disrupted nocturnal sleep patterns as well as by pain medications. There is emerging evidence that sleep disorders and daytime sleepiness are clinically relevant with respect to the quality of life in cancer patients. To distinguish daytime sleepiness from fatigue may be challenging in these conditions so that a comprehensive approach is advisable. Disrupted nocturnal sleep and daytime sleepiness are reportedly frequent in gastrointestinal disorders such as irritable bowel syndrome (IBS) and in cirrhosis. Daytime sleepiness has recently been reported to be associated with hepatic encephalopathy in cirrhotics. As far as the management of daytime sleepiness in chronic pain, cancer and gastrointestinal disorders is concerned, both pharmacological and behavioural treatments should be taken into account with the main goal being to improve nocturnal sleep quality. The Z-drugs and short half-life benzodiazepines proved to be effective in improving sleep continuity and stability in these patients. Activating drugs were also reportedly of use and appropriate to increase daytime alertness. Finally, specific treatments for the basic pathology and for comorbid sleep disorders such as sleep disordered breathing and Restless Legs Syndrome should be done.

Original languageEnglish
Title of host publicationSleepiness and human impact assessment
PublisherSpringer-Verlag Italia s.r.l.
Pages279-285
Number of pages7
ISBN (Print)9788847053885, 8847053870, 9788847053878
DOIs
Publication statusPublished - Jan 1 2014

Fingerprint

Gastrointestinal Neoplasms
Fibromyalgia
Sleep
Chronic Pain
Restless Legs Syndrome
Hepatic Encephalopathy
Irritable Bowel Syndrome
Sleep Apnea Syndromes
Benzodiazepines
Pharmaceutical Preparations
Fatigue
Half-Life
Fibrosis
Quality of Life
Pharmacology
Pathology
Pain
Cancer Pain
Therapeutics
Neoplasms

Keywords

  • Cancer
  • Fibromyalgia
  • Gastrointestinal disorders
  • Pain
  • Sleepiness

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Manni, R., Cremascoli, R., & Terzaghi, M. (2014). Pain, cancer, fibromyalgia and gastrointestinal disorders. In Sleepiness and human impact assessment (pp. 279-285). Springer-Verlag Italia s.r.l.. https://doi.org/10.1007/978-88-470-5388-5_26

Pain, cancer, fibromyalgia and gastrointestinal disorders. / Manni, Raffaele; Cremascoli, Riccardo; Terzaghi, Michele.

Sleepiness and human impact assessment. Springer-Verlag Italia s.r.l., 2014. p. 279-285.

Research output: Chapter in Book/Report/Conference proceedingChapter

Manni, R, Cremascoli, R & Terzaghi, M 2014, Pain, cancer, fibromyalgia and gastrointestinal disorders. in Sleepiness and human impact assessment. Springer-Verlag Italia s.r.l., pp. 279-285. https://doi.org/10.1007/978-88-470-5388-5_26
Manni R, Cremascoli R, Terzaghi M. Pain, cancer, fibromyalgia and gastrointestinal disorders. In Sleepiness and human impact assessment. Springer-Verlag Italia s.r.l. 2014. p. 279-285 https://doi.org/10.1007/978-88-470-5388-5_26
Manni, Raffaele ; Cremascoli, Riccardo ; Terzaghi, Michele. / Pain, cancer, fibromyalgia and gastrointestinal disorders. Sleepiness and human impact assessment. Springer-Verlag Italia s.r.l., 2014. pp. 279-285
@inbook{ba7c123bb7fe465a95a79a375d4600d1,
title = "Pain, cancer, fibromyalgia and gastrointestinal disorders",
abstract = "Daytime sleepiness is very frequent in chronic pain sufferers and it is underpinned by disrupted nocturnal sleep patterns as well as by pain medications. There is emerging evidence that sleep disorders and daytime sleepiness are clinically relevant with respect to the quality of life in cancer patients. To distinguish daytime sleepiness from fatigue may be challenging in these conditions so that a comprehensive approach is advisable. Disrupted nocturnal sleep and daytime sleepiness are reportedly frequent in gastrointestinal disorders such as irritable bowel syndrome (IBS) and in cirrhosis. Daytime sleepiness has recently been reported to be associated with hepatic encephalopathy in cirrhotics. As far as the management of daytime sleepiness in chronic pain, cancer and gastrointestinal disorders is concerned, both pharmacological and behavioural treatments should be taken into account with the main goal being to improve nocturnal sleep quality. The Z-drugs and short half-life benzodiazepines proved to be effective in improving sleep continuity and stability in these patients. Activating drugs were also reportedly of use and appropriate to increase daytime alertness. Finally, specific treatments for the basic pathology and for comorbid sleep disorders such as sleep disordered breathing and Restless Legs Syndrome should be done.",
keywords = "Cancer, Fibromyalgia, Gastrointestinal disorders, Pain, Sleepiness",
author = "Raffaele Manni and Riccardo Cremascoli and Michele Terzaghi",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-88-470-5388-5_26",
language = "English",
isbn = "9788847053885",
pages = "279--285",
booktitle = "Sleepiness and human impact assessment",
publisher = "Springer-Verlag Italia s.r.l.",

}

TY - CHAP

T1 - Pain, cancer, fibromyalgia and gastrointestinal disorders

AU - Manni, Raffaele

AU - Cremascoli, Riccardo

AU - Terzaghi, Michele

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Daytime sleepiness is very frequent in chronic pain sufferers and it is underpinned by disrupted nocturnal sleep patterns as well as by pain medications. There is emerging evidence that sleep disorders and daytime sleepiness are clinically relevant with respect to the quality of life in cancer patients. To distinguish daytime sleepiness from fatigue may be challenging in these conditions so that a comprehensive approach is advisable. Disrupted nocturnal sleep and daytime sleepiness are reportedly frequent in gastrointestinal disorders such as irritable bowel syndrome (IBS) and in cirrhosis. Daytime sleepiness has recently been reported to be associated with hepatic encephalopathy in cirrhotics. As far as the management of daytime sleepiness in chronic pain, cancer and gastrointestinal disorders is concerned, both pharmacological and behavioural treatments should be taken into account with the main goal being to improve nocturnal sleep quality. The Z-drugs and short half-life benzodiazepines proved to be effective in improving sleep continuity and stability in these patients. Activating drugs were also reportedly of use and appropriate to increase daytime alertness. Finally, specific treatments for the basic pathology and for comorbid sleep disorders such as sleep disordered breathing and Restless Legs Syndrome should be done.

AB - Daytime sleepiness is very frequent in chronic pain sufferers and it is underpinned by disrupted nocturnal sleep patterns as well as by pain medications. There is emerging evidence that sleep disorders and daytime sleepiness are clinically relevant with respect to the quality of life in cancer patients. To distinguish daytime sleepiness from fatigue may be challenging in these conditions so that a comprehensive approach is advisable. Disrupted nocturnal sleep and daytime sleepiness are reportedly frequent in gastrointestinal disorders such as irritable bowel syndrome (IBS) and in cirrhosis. Daytime sleepiness has recently been reported to be associated with hepatic encephalopathy in cirrhotics. As far as the management of daytime sleepiness in chronic pain, cancer and gastrointestinal disorders is concerned, both pharmacological and behavioural treatments should be taken into account with the main goal being to improve nocturnal sleep quality. The Z-drugs and short half-life benzodiazepines proved to be effective in improving sleep continuity and stability in these patients. Activating drugs were also reportedly of use and appropriate to increase daytime alertness. Finally, specific treatments for the basic pathology and for comorbid sleep disorders such as sleep disordered breathing and Restless Legs Syndrome should be done.

KW - Cancer

KW - Fibromyalgia

KW - Gastrointestinal disorders

KW - Pain

KW - Sleepiness

UR - http://www.scopus.com/inward/record.url?scp=84930829799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930829799&partnerID=8YFLogxK

U2 - 10.1007/978-88-470-5388-5_26

DO - 10.1007/978-88-470-5388-5_26

M3 - Chapter

SN - 9788847053885

SN - 8847053870

SN - 9788847053878

SP - 279

EP - 285

BT - Sleepiness and human impact assessment

PB - Springer-Verlag Italia s.r.l.

ER -